Baxter International Inc vs CAVA Group Inc — how do they compare? Baxter International Inc trades at $26.11 (market cap $13.51B), while CAVA Group Inc trades at $61.01 (market cap $7.68B). The key difference: Baxter International Inc is the larger of the two by market cap, and Baxter International Inc pays a 0.15% dividend while CAVA Group Inc pays none. Which is the better fit depends on your goals.
| BAX | CAVA | |
|---|---|---|
Market Cap | $13.51B | $7.68B |
Sector | Health | Consumer Cyclical |
52-Week High | $28.35 | $97.39 |
52-Week Low | $15.80 | $43.59 |
Enterprise Value | $21.03B | $7.77B |
Dividend Yield | 0.15% | — |
Signals from Pluang's Aura AI — not financial advice
Baxter International (BAX) trades at $25.28, down 3.25% today, with mixed technical signals showing a neutral overall outlook. The company reported strong Q2 2026 earnings beats with EPS of $0.56 versus $0.37 expected, and raised full-year guidance, indicating operational improvement. However, negative net income margins and elevated P/E ratio of 87.85 present valuation concerns despite recent positive momentum.
The stock shows turnaround potential with recent earnings outperformance and debt reduction initiatives, but faces headwinds from persistent profitability challenges and high valuation multiples. Analyst consensus leans neutral with a $25.43 price target, suggesting limited near-term upside from current levels amid ongoing operational restructuring.
CAVA stock declined 8.75% to $61.08, reflecting market reaction to food safety concerns despite strong Q2 2026 earnings beats. The company maintains robust revenue growth (31% in Q2) and expanding store footprint, but faces margin pressure from rising costs. Technical indicators show bearish momentum with the stock trading below key support levels, while fundamentals reveal premium valuations with P/E of 117.41 and P/S of 5.66.
The investment case balances rapid growth potential against execution risks. Analyst consensus remains strongly bullish with $87.17 price target (43% upside), but investors must weigh food safety headwinds, margin compression, and rich valuations against the company's compelling unit economics and market share gains in fast-casual dining.
Trailing returns across standard periods
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →CAVA is a Mediterranean fast-casual restaurant brand in the US. It offers customizable bowls, salads, and pitas featuring healthy ingredients, while also selling its signature dips and dressings in grocery stores.
Read more on CAVA →